SEC Filing Analysis: EXACT SCIENCES CORP

Executive Summary

• Trading Significance: Low
• Key Takeaway: An officer at EXACT Sciences has filed a notice of intent to sell 1,000 shares of common stock, valued at approximately $70,000, under a pre-established 10b5-1 trading plan.
• Market Impact: The transaction is of very low monetary value and represents an insignificant fraction of the company's market capitalization, suggesting a negligible impact on the stock.

Company Information

Field	Value
Company	EXACT SCIENCES CORP
Ticker Symbol	EXAS (Inferred)
CIK	0001124140
Industry	Medical Laboratories

Insider Information

Field	Value
Name	Herriott James
CIK	0001957680
Title/Position	Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	144
Transaction Date	2025-11-19 (Approximate)
Transaction Code	N/A
Security Type	Common Stock
Shares Involved	1,000
Price Per Share	$70.00
Total Value	$70,000.00
Shares Owned After	Not Disclosed
Ownership Type	Not Disclosed

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$70,000.00
% of Market Cap	0.00055%
Shares Transacted	1,000
% of Shares Outstanding	0.00053%
Post-Transaction Ownership	Not Disclosed
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: With a market capitalization of $12.70 billion, this $70,000 transaction is financially immaterial to the company.
• Transaction Significance: The sale represents a negligible percentage of both market capitalization and shares outstanding, classifying it as a routine transaction for personal financial management rather than a significant strategic move.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The sale is extremely small relative to the company's size and is being conducted under a 10b5-1 plan, which reduces its signaling value. The filing also notes other recent sales by the insider, indicating a pattern of periodic, small-scale liquidation.

Volume & Sentiment

• Expected Volume Impact: None. The number of shares is too small to affect daily trading volume.
• Sentiment Indicator: Neutral. The market is unlikely to react to a sale of this size, especially under a trading plan.

Additional Context

Special Circumstances

• The sale is planned under a 10b5-1 trading plan adopted on March 3, 2025. This indicates the sale was pre-scheduled and not based on immediate, non-public information.